These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37874348)

  • 61. A novel long noncoding RNA, LOC440173, promotes the progression of esophageal squamous cell carcinoma by modulating the miR-30d-5p/HDAC9 axis and the epithelial-mesenchymal transition.
    Wang G; Feng B; Niu Y; Wu J; Yang Y; Shen S; Guo Y; Liang J; Guo W; Dong Z
    Mol Carcinog; 2020 Dec; 59(12):1392-1408. PubMed ID: 33079409
    [TBL] [Abstract][Full Text] [Related]  

  • 62. miR-133a-3p suppresses cell proliferation, migration, and invasion and promotes apoptosis in esophageal squamous cell carcinoma.
    Yin Y; Du L; Li X; Zhang X; Gao Y
    J Cell Physiol; 2019 Aug; 234(8):12757-12770. PubMed ID: 30537034
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Tumor Cell-Derived Complement Component C1r Acts as a Prognostic Biomarker and Promotes Esophageal Squamous Cell Carcinoma Progression.
    Tang M; Zhao S; Ren L; Li Q; Li L; Wang C; Meng C; Chen Y; Hu W
    Front Biosci (Landmark Ed); 2024 Apr; 29(4):138. PubMed ID: 38682192
    [TBL] [Abstract][Full Text] [Related]  

  • 64. FOXD3 suppresses epithelial-mesenchymal transition through direct transcriptional promotion of SMAD7 in esophageal squamous cell carcinoma.
    Wu Z; Li Y; Niu Y; Lu J; Yan Z; Xu T; Guo Y; Dong Z; Guo W
    Mol Carcinog; 2021 Dec; 60(12):859-873. PubMed ID: 34551139
    [TBL] [Abstract][Full Text] [Related]  

  • 65. miR-25 mediates metastasis and epithelial-mesenchymal-transition in human esophageal squamous cell carcinoma via regulation of E-cadherin signaling.
    Liu B; Li X; Li C; Xu R; Sun X
    Bioengineered; 2019 Dec; 10(1):679-688. PubMed ID: 31679450
    [TBL] [Abstract][Full Text] [Related]  

  • 66. SOX12 contributes to the activation of the JAK2/STAT3 pathway and malignant transformation of esophageal squamous cell carcinoma.
    Li C; Zhu M; Zhu J; Lu Q; Shi B; Sun B; Chen H
    Oncol Rep; 2021 Jan; 45(1):129-138. PubMed ID: 33416144
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Expression of microRNA-17-5p in esophageal squamous cell carcinoma and its effects on cell proliferation and invasion].
    Xu H; Meng XR; Zhou Y; Wang F
    Zhonghua Zhong Liu Za Zhi; 2020 Feb; 42(2):105-113. PubMed ID: 32135643
    [No Abstract]   [Full Text] [Related]  

  • 68. IQGAP1 overexpression attenuates chemosensitivity through YAP-mediated ferroptosis inhibition in esophageal squamous cell cancer cells.
    Li X; Zhao X; Su X; Wen J; Yang S; Qin Y; Yan S; Yao Y; Li X; Wang X
    Arch Biochem Biophys; 2024 Aug; 758():110064. PubMed ID: 38897534
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Expression of Glutathione Peroxidase4 in Patients with Esophageal Squamous Carcinoma and Its Impact on the Radiosensitivity of Esophageal Squamous Carcinoma.
    Chen C; Gu W; Shao Y; Zheng P; Jiang J
    Ann Clin Lab Sci; 2024 Mar; 54(2):160-169. PubMed ID: 38802161
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Downregulation of AAA-domain-containing protein 2 restrains cancer stem cell properties in esophageal squamous cell carcinoma via blockade of the Hedgehog signaling pathway.
    Li N; Yu Y; Wang B
    Am J Physiol Cell Physiol; 2020 Jul; 319(1):C93-C104. PubMed ID: 31747529
    [TBL] [Abstract][Full Text] [Related]  

  • 71. ATAD2 interacts with C/EBPβ to promote esophageal squamous cell carcinoma metastasis via TGF-β1/Smad3 signaling.
    Cao LJ; Zhang YJ; Dong SQ; Li XZ; Tong XT; Chen D; Wu ZY; Zheng XH; Xue WQ; Jia WH; Zhang JB
    J Exp Clin Cancer Res; 2021 Mar; 40(1):109. PubMed ID: 33757572
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Circular RNA hsa_circ_0000654 promotes esophageal squamous cell carcinoma progression by regulating the miR-149-5p/IL-6/STAT3 pathway.
    Xu Z; Tie X; Li N; Yi Z; Shen F; Zhang Y
    IUBMB Life; 2020 Mar; 72(3):426-439. PubMed ID: 31778020
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Nicotinamide N-methyltransferase decreases 5-fluorouracil sensitivity in human esophageal squamous cell carcinoma through metabolic reprogramming and promoting the Warburg effect.
    Cui Y; Yang D; Wang W; Zhang L; Liu H; Ma S; Guo W; Yao M; Zhang K; Li W; Zhang Y; Guan F
    Mol Carcinog; 2020 Aug; 59(8):940-954. PubMed ID: 32367570
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Pharmacological targeting of TNS3 with histone deacetylase inhibitor as a therapeutic strategy in esophageal squamous cell carcinoma.
    Shi Y; Xiang Z; Yang H; Khan S; Li R; Zhou S; Ullah S; Zhang J; Liu B
    Aging (Albany NY); 2021 May; 13(11):15336-15352. PubMed ID: 34047714
    [TBL] [Abstract][Full Text] [Related]  

  • 75. FAP positive cancer-associated fibroblasts promote tumor progression and radioresistance in esophageal squamous cell carcinoma by transferring exosomal lncRNA AFAP1-AS1.
    Zhou X; Tong Y; Yu C; Pu J; Zhu W; Zhou Y; Wang Y; Xiong Y; Sun X
    Mol Carcinog; 2024 Oct; 63(10):1922-1937. PubMed ID: 38934786
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Human umbilical cord mesenchymal stem cells-derived exosomes deliver microRNA-375 to downregulate ENAH and thus retard esophageal squamous cell carcinoma progression.
    He Z; Li W; Zheng T; Liu D; Zhao S
    J Exp Clin Cancer Res; 2020 Jul; 39(1):140. PubMed ID: 32698859
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Transcription factor NFE2L3 promotes the proliferation of esophageal squamous cell carcinoma cells and causes radiotherapy resistance by regulating IL-6.
    Chen T; Xu B; Chen H; Sun Y; Song J; Sun X; Zhang X; Hua W
    Comput Methods Programs Biomed; 2022 Nov; 226():107102. PubMed ID: 36108571
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Antitumour effects of artesunate via cell cycle checkpoint controls in human oesophageal squamous carcinoma cells.
    Mao L; Deng G; Li M; Lu SH; Jiang W; Yu X
    Eur J Med Res; 2024 May; 29(1):293. PubMed ID: 38773551
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Small molecule agonists of PPAR-γ exert therapeutic effects in esophageal cancer.
    Sawayama H; Ishimoto T; Watanabe M; Yoshida N; Sugihara H; Kurashige J; Hirashima K; Iwatsuki M; Baba Y; Oki E; Morita M; Shiose Y; Baba H
    Cancer Res; 2014 Jan; 74(2):575-85. PubMed ID: 24272485
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Arntl-induced upregulation of DUSP1 inhibits tumor progression in esophageal squamous cell carcinoma by inactivating ERK signaling.
    Wang J; Jia Q; Sun J; Wu S; Wei L; Yao W
    Cancer Biol Ther; 2024 Dec; 25(1):2408042. PubMed ID: 39341782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.